Agilent Technologies Inc (BSP:A1GI34)
R$ 403.6 0 (0%) Market Cap: 231.93 Bil Enterprise Value: 238.48 Bil PE Ratio: 28.59 PB Ratio: 6.71 GF Score: 86/100

Q3 2024 Agilent Technologies Inc Earnings Call Transcript

Aug 21, 2024 / 08:30PM GMT
Release Date Price: R$371.26

Key Points

Positve
  • Agilent Technologies Inc (A) posted better-than-expected revenue and earnings for Q3 2024.
  • Earnings per share of $1.32 exceeded the high end of guidance by $0.04.
  • The company raised its guidance at the midpoint for both revenue and EPS for the full year.
  • Agilent Technologies Inc (A) announced two strategic acquisitions focused on biopharma and digital ecosystem enhancement.
  • The Agilent CrossLab Group delivered a record operating margin of 34%, demonstrating the strength of its recurring-revenue business.
Negative
  • Revenue of $1.578 billion declined by 4.4% year-over-year.
  • The Life Sciences and Applied Markets Group reported a 7% decline in revenue.
  • The Diagnostics and Genomics Group posted an 8% decline in revenue.
  • China revenue declined by 11%, with quarterly revenue improving only sequentially.
  • Capital-equipment budgets remained constrained, impacting the instrument side of the business.
Operator

Ladies and gentlemen, welcome to the Agilent Technologies Q3 2024 earnings call. My name is Regina, and I will be coordinating your call today. (Operator Instructions). I will now hand you over to your host Parmeet Ahuja, to begin. Please go ahead.

Parmeet Ahuja
Agilent Technologies Inc - Investor Relation

Thank you, and welcome everyone to Agilent's conference call for the third quarter of fiscal year 2024. With me are Padraig McDonnell, Agilent president and CEO, and Bob McMahon, Agilent senior vice president and CFO.

Joining in the Q&A will be Phil Binns, president of the Agilent Life Sciences and Applied Markets Group; Simon May, president of the Agilent Diagnostics and Genomics Group; and Angelica Riemann, president of the Agilent CrossLab Group.

This presentation is being webcast live. The news release for our third-quarter financial results, investor presentation, and information to supplement todayâs discussion, along with a recording of this webcast are available on our website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot